FOR PLUS PHARMA
ActiveSummary
The computed 12-month bankruptcy probability of FOR PLUS PHARMA is 3.4% (moderate). The 2025 annual accounts show equity of €99,809 and a net result of €82,647. Equity is shrinking by about 27% per year and would, assuming unchanged policy, indicatively turn negative around financial year 2026. Its solvency ranks better than 38% of 13,365 sector peers (NACE 46, financial year 2025). The company has been active since 2020 and the Belgian Official Gazette contains no insolvency or warning signals.
Register details
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 11 October 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.
Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.
Sites & property
1 parcel
| Cadastral parcel | Region | Area | Buildings | Height / floors |
|---|---|---|---|---|
| 56074B0182/00H002 | Wallonia | 5,578 m² | 1 · 1,377 m² | 7.7 m · 2 |